|Articles|April 11, 2017

Accenture, BioCelerate Collaborate on Preclinical Platform

Accenture has announced a collaboration with BioCelerate, a subsidiary of TransCelerate, to develop a platform.

Accenture has announced a collaboration with BioCelerate, a subsidiary of TransCelerate, to develop a platform allowing its member companies to aggregate and analyze preclinical and clinical information in the hopes of improving drug development efficiency.

Read the full release here

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.